Arbutus Biopharma Corp Stock Issued During Period, Shares, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Arbutus Biopharma Corp stock issued during period, shares, conversion of convertible securities for fiscal 2016 was 0.00 shares.
- Arbutus Biopharma Corp stock issued during period, shares, conversion of convertible securities for fiscal 2015 was 0.00 shares, a 100.00% decline from fiscal 2014.
- Arbutus Biopharma Corp stock issued during period, shares, conversion of convertible securities for fiscal 2014 was 5.29K shares, a 97.35% decline from fiscal 2013.
- Arbutus Biopharma Corp stock issued during period, shares, conversion of convertible securities for fiscal 2013 was 199.76K shares, a 416.94% increase from fiscal 2012.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 3 month | Stock Issued During Period, Shares, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2016-12-31 | 0.00 shares 10-K · filed 2018-03-16 | |
| 2015-12-31 | 0.00 shares 10-K · filed 2017-03-22 | |
| 2014-12-31 | 5.29K shares 10-K · filed 2016-03-09 | |
| 2013-12-31 | 199.76K shares 10-K · filed 2015-03-13 | |
| 2012-12-31 | 38.64K shares 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |